Stockscreener 앱 받기
0.7922
3.40%
-0.0279
시간 외 거래:
.79
-0.0022
-0.28%
Precigen Inc 주식(PGEN)의 최신 뉴스
HC Wainwright Reduces Earnings Estimates for Precigen - MarketBeat
PGEN stock touches 52-week low at $0.78 amid market challenges - Investing.com Canada
HC Wainwright Reiterates Buy Rating for Precigen (NASDAQ:PGEN) - MarketBeat
Precigen Inc. (PGEN) Quarterly 10-Q Report - Quartzy
Precigen, Inc. (PGEN) Reports Q3 Loss, Lags Revenue Estimates - Yahoo Finance
Precigen Inc (PGEN) Q3 2024 Earnings: EPS Misses at $(0.09), Rev - GuruFocus.com
Precigen, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Precigen Reports Third Quarter 2024 Financial Results and Business Updates - Quantisnow
Precigen (NASDAQ:PGEN) Shares Cross Below 200 Day Moving AverageHere's Why - MarketBeat
Precigen CEO to Present at Stifel 2024 Healthcare Conference: Gene Therapy Innovation Spotlight | PGEN Stock News - StockTitan
Precigen, Inc. (NASDAQ:PGEN) Receives $7.00 Consensus Price Target from Brokerages - Defense World
Precigen, Inc. (NASDAQ:PGEN) Receives $7.00 Consensus Target Price from Analysts - MarketBeat
PGEN (Precigen) EBITDA per Share : $-0.52 (TTM As of Jun. 2024) - GuruFocus.com
Precigen Announces Pricing of $30.0 Million Public Offering of C - GuruFocus.com
Iridian Asset Management LLC CT Grows Stock Position in Precigen, Inc. (NASDAQ:PGEN) - MarketBeat
PGEN stock touches 52-week low at $0.82 amid market challenges - Investing.com Australia
Precigen to Announce Fourth Quarter and Full Year 2023 Financial Results on March 19th - GuruFocus.com
High Growth Tech Stocks To Watch In October 2024 - Simply Wall St
Should you Hold Precigen (PGEN)? - Insider Monkey
Precigen, Inc. (NASDAQ:PGEN) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
A company insider recently bought 58,823 shares of Precigen Inc [PGEN]. Should You Buy? - Knox Daily
Precigen reclaims rights after terminating license agreement By Investing.com - Investing.com Australia
Precigen Inc (PGEN) stock analysis: A simple moving average approach - US Post News
Precigen reclaims rights after terminating license agreement - Investing.com India
Precigen Terminates License Agreement With Alaunos Therapeutics - MarketWatch
Precigen Regains Full Control of Technology Post Agreement Termination - TipRanks
Precigen : Termination of Material Agreement Form 8 K - Marketscreener.com
Upward Trajectory: Precigen Inc (PGEN) Posts a Slidee, Closing at 0.85 - The Dwinnex
When Will Precigen, Inc. (NASDAQ:PGEN) Turn A Profit? - Simply Wall St
PGEN’s latest rating updates from top analysts. - Knox Daily
Is Precigen Inc (PGEN) positioned for future growth? - SETE News
SVP, IP Affairs Perez Jeffrey Thomas acquire 58,823 shares of Precigen Inc [PGEN] - Knox Daily
Precigen (NASDAQ:PGEN) Shares Cross Below Two Hundred Day Moving AverageShould You Sell? - MarketBeat
How to interpret Precigen Inc (PGEN)’s stock chart patterns - US Post News
5 "Best" Publicly Traded Synthetic Biology Companies - Securities.io
Financial Analysis: Precigen Inc (PGEN)’s Ratios Unveil Key Insights - The Dwinnex
Precigen Inc (PGEN) receives an Underweight rating from JP Morgan - Knox Daily
Precigen's SWOT analysis: biotech firm's stock rides on PRGN-2012 success - Investing.com
Precigen Inc (PGEN)’s stock performance: a year in review - US Post News
Biotech Co. Precigen Announces IP Exec's Departure - Law360
Precigen Inc (PGEN) may enjoy gains as insiders got busy in the recent days - Knox Daily
Precigen senior VP Jeffrey Perez quits - Investing.com
J.P. Morgan cuts Precigen to underweight, cites burn rate - MSN
Precigen Inc Inc. (PGEN) Price Performance: A Technical Analysis Perspective - The InvestChronicle
Precigen Inc [NASDAQ: PGEN] Sees Increase in Stock Value - Knox Daily
What is Precigen Inc (PGEN) Stock Return on Shareholders’ Capital? - SETE News
Investing in Precigen Inc (PGEN): What You Must Know - Knox Daily
The Precigen Inc (PGEN) had a good session last reading, didn’t it? - US Post News
Precigen Inc’s Market Journey: Closing Weak at 1.00, Down -4.78 - The Dwinnex
Analysts Set Precigen, Inc. (NASDAQ:PGEN) Target Price at $7.00 - MarketBeat
Principal Financial Group Inc. Sells 37,802 Shares of Precigen, Inc. (NASDAQ:PGEN) - Defense World
Precigen to Participate in the 2024 Cantor Global Healthcare Conference - The Malaysian Reserve
Precigen to Participate in the 2024 Cantor Global Healthcare Conference – Company Announcement - Financial Times
Precigen to Participate in the 2024 Cantor Global Healthcare Conference | PGEN Stock News - StockTitan
PGEN Shares Experience Surge in Value - Knox Daily
Precigen Inc (PGEN) is looking forward to a strong quarter - SETE News
Randal J. Kirk - Forbes
While institutions own 26% of Precigen, Inc. (NASDAQ:PGEN), private equity firms are its largest shareholders with 43% ownership - Yahoo Finance
Investor’s Toolkit: Key Ratios for Assessing Precigen Inc (PGEN)’s Performance - The Dwinnex
Investing in Precigen Inc (PGEN) might be a great opportunity, but the stock is a bit undervalued - US Post News
Precigen Inc [PGEN] stock for 50,000 USD was acquired by Perez Jeffrey Thomas - Knox Daily
Shareholders in Precigen (NASDAQ:PGEN) have lost 85%, as stock drops 15% this past week - Simply Wall St
3.66%
1.11%
자본화:
|
볼륨(24시간):